{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:17:09Z","timestamp":1784265429671,"version":"3.55.0"},"reference-count":8,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000651","name":"Leukaemia and Lymphoma Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000651","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK-52798"],"award-info":[{"award-number":["DK-52798"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.leukres.2011.10.002","type":"journal-article","created":{"date-parts":[[2011,10,28]],"date-time":"2011-10-28T20:51:16Z","timestamp":1319835076000},"page":"245-249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Evidence for functional trace amine associated receptor-1 in normal and malignant B cells"],"prefix":"10.1016","volume":"36","author":[{"given":"Agata M.","family":"Wasik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Millan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Scanlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas M.","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2011.10.002_bib0005","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.semcancer.2007.12.007","article-title":"Harnessing serotonergic and dopaminergic pathways for lymphoma therapy: evidence and aspirations","volume":"18","author":"Barnes","year":"2008","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.leukres.2011.10.002_bib0010","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.leukres.2010.03.007","article-title":"SLC6A4 expression and anti-proliferative responses to serotonin transporter ligands chlomipramine and fluoxetine in B-cell malignancies","volume":"36","author":"Chamba","year":"2010","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2011.10.002_bib0015","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1096\/fj.04-3477fje","article-title":"The serotonin transporter (SLC6A4) is present in B-cell clones of diverse malignant origin: probing a potential anti-tumor target for psychotropics","volume":"19","author":"Meredith","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.leukres.2011.10.002_bib0020","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1039\/c0md00108b","article-title":"Redesigning the designer drug ecstasy: non-psychoactive MDMA analogues exhibiting Burkitt's lymphoma cytotoxicity","volume":"1","author":"Gandy","year":"2010","journal-title":"Med Chem Commun"},{"key":"10.1016\/j.leukres.2011.10.002_bib0025","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1124\/mol.109.055970","article-title":"Trace amine-associated receptors as emerging therapeutic targets","volume":"76","author":"Sotnikova","year":"2009","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.leukres.2011.10.002_bib0030","first-page":"164","article-title":"Rhesus monkey trace amine-associated receptor 1 signaling: enhancement by monoamine transporters and attenuation by the D2 autoreceptor in vitro","volume":"116","author":"Xie","year":"2007","journal-title":"JPET"},{"key":"10.1016\/j.leukres.2011.10.002_bib0035","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jneuroim.2007.08.006","article-title":"Expression of neuronal trace amine-associated receptor (Taar) mRNAs in leukocytes","volume":"192","author":"Nelson","year":"2007","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.leukres.2011.10.002_bib0040","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.pharmthera.2007.06.007","article-title":"Trace amine-associated receptor 1-family archetype or iconoclast?","volume":"116","author":"Grandy","year":"2007","journal-title":"Pharmacol Ther"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212611004747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212611004747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T16:43:18Z","timestamp":1777999398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212611004747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":8,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0145212611004747"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2011.10.002","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evidence for functional trace amine associated receptor-1 in normal and malignant B cells","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2011.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}